Methyldrostanolone

The effect of Methyldrostanolone (Superdrol):

In principle, the effect of which can be compared with Methyldrostanolone of classic Drostanolon. Methyldrostanolone can as already mentioned not be converted to estrogen. In practice, it means no estrogen-related side effects. This could be water retention or gynecomastia.
But the interesting aspects of Methyldrostanolone regarding estrogen begins at this point actually only. If the original medical field of application of Methyldrostanolone / Drostanolon you look, then you will find that Drostanolon not for building body tissues but as a drug to treat certain types of breast cancer was used in women.

Use of Methyldrostanolone:

This field of application of Superdrol (Methyldrostanolone) based on the active ingredient Drostanolone property aromatization (conversion into estrogen) of endogenous testosterone – to reduce by inhibiting the aromatase enzyme – and also by exogenously added flavoring anabolic androgenic steroids. It is further believed that Superdrol (Methyldrostanolone) interacts with additional estrogen by blocking estrogen receptors, thereby reducing the effect of existing estrogen. This means for the user that using Superdrol (Methyldrostanolone) the estrogenic side effects of other anabolic androgenic steroids may be reduced and may be waived under certain circumstances the use of an additional aromatase inhibitor like Arimidex or an estrogen receptor blocker such as tamoxifen (Nolvadex).

Moreover, the use of Methyldrostanolone promotes lipolysis (release of fat from the fat cells) and causes an increase in the number of androgen receptors in the adipose tissue, causing the fat reduction is promoted. Further increase androgens components of Superdrol (Methyldrowtanolon) aggression, which is particularly evident in the context of a reduced calorie diet can have a positive effect on the exercise intensity.